Gainers
- Kiromic BioPharma KRBP shares moved upwards by 17.3% to $0.4 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.2 million. The company's, Q1 earnings came out 3 days ago.
- CymaBay Therapeutics CBAY shares moved upwards by 13.15% to $2.15. The market value of their outstanding shares is at $182.0 million. As per the press release, Q1 earnings came out 4 days ago.
- Landos Biopharma LABP shares rose 12.75% to $0.84. The market value of their outstanding shares is at $33.8 million. As per the press release, Q1 earnings came out 4 days ago.
- Qualigen Therapeutics QLGN stock moved upwards by 12.32% to $0.59. The company's market cap stands at $20.6 million. The company's, Q1 earnings came out 3 days ago.
- Calliditas Therapeutics CALT shares rose 10.65% to $16.82. The market value of their outstanding shares is at $447.1 million. As per the news, the Q1 earnings report came out today.
- Sensei Biotherapeutics SNSE stock increased by 10.58% to $1.88. The market value of their outstanding shares is at $57.5 million.
Losers
- Baudax Bio BXRX stock declined by 29.2% to $0.83 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.3 million.
- Doximity DOCS shares fell 13.09% to $29.35. The market value of their outstanding shares is at $5.6 billion. As per the news, the Q4 earnings report came out yesterday.
- Scopus BioPharma SCPS shares decreased by 9.57% to $0.37. The company's market cap stands at $7.8 million.
- vTv Therapeutics VTVT stock fell 9.07% to $0.4. The market value of their outstanding shares is at $26.7 million. As per the press release, Q1 earnings came out 4 days ago.
- AIkido Pharma AIKI shares decreased by 8.25% to $0.3. The company's market cap stands at $26.8 million. The company's, Q1 earnings came out 2 days ago.
- China SXT Pharmaceuticals SXTC shares fell 7.05% to $0.15. The market value of their outstanding shares is at $4.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in